Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

The point-of-care technology sector has been witnessing significant growth recently, driven by ongoing innovations and increasing healthcare demands. This market is evolving rapidly as healthcare providers seek faster, more accessible diagnostic solutions, especially in decentralized and homecare settings. Let’s explore the market’s current size, key growth drivers, segmentation, industry trends, leading companies, and regional outlook.

Point-of-Care Technology Market Size and Growth Forecast

The point-of-care technology market has experienced substantial expansion over recent years. It is anticipated to grow from $43.21 billion in 2025 to $47.41 billion in 2026, reflecting a compound annual growth rate (CAGR) of 9.7%. This growth during the historical period is mainly linked to a heavy reliance on centralized lab testing, limited access to rapid diagnostics in remote locations, an increasing burden of infectious diseases, rising hospital patient volumes, and early adoption of fundamental point-of-care devices.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27390&type=smp

Looking ahead, the market is expected to expand further, reaching $67.94 billion by 2030 with a CAGR of 9.4%. Factors contributing to this forecasted growth include advances in microfluidics and polymerase chain reaction (PCR) technologies, a rising prevalence of chronic and lifestyle diseases, the expansion of homecare and decentralized healthcare models, increasing healthcare digitization, and supportive regulatory policies encouraging rapid diagnostics. Key trends shaping the future include growing demand for rapid point-of-care tests, wider adoption of home and remote testing solutions, growth in portable and handheld diagnostic devices, and a stronger focus on user-friendly and fast-result systems.

Factors Propelling the Point-of-Care Technology Market

One of the main forces driving growth in the point-of-care technology market is the rising incidence of chronic conditions. Chronic diseases are long-term health issues that require ongoing management and lifestyle adjustments. Sedentary lifestyles, characterized by prolonged sitting and limited physical activity, are increasing risks for illnesses such as heart disease and diabetes. Point-of-care technologies facilitate the management of these chronic conditions by providing quick, on-site diagnostic testing, which is particularly beneficial in clinical, home, and remote care environments.

Access The Complete Point-of-Care Technology Market Report:

https://www.thebusinessresearchcompany.com/report/point-of-care-technology-global-market-report

This technology helps minimize treatment delays by delivering immediate results, enhancing patient monitoring, and improving overall healthcare convenience. For example, in June 2024, the UK’s National Health Service reported that 3,615,330 patients registered with general practitioners were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023, marking an 18% increase from 3,065,825 cases in 2022. This growing prevalence of chronic illness is a significant driver of market expansion.

Point-of-Care Technology Market Segmentation and Revenue Contributors

This report segments the point-of-care technology market across several dimensions:

By Product Type:

– Diagnostics Devices

– Monitoring Devices

– Therapeutic Devices

– Data Management Systems

By Ownership Model:

– Standalone Solutions

– Integrated Solutions

– Cloud-Based Solutions

By Technology:

– Microfluidics

– Polymerase Chain Reaction (PCR)

– Immunoassays

By Application:

– Infectious Disease Testing

– Glucose Monitoring

– Cardiometabolic Monitoring

– Pregnancy and Fertility Testing

– Other Applications

By End-User:

– Hospitals

– Clinics

– Homecare Settings

– Ambulatory Surgical Centers

Further subcategories include diagnostics devices such as blood glucose monitoring, infectious disease testing, cardiac marker testing, coagulation testing, pregnancy and fertility testing, urinalysis, hematology, and cholesterol testing. Monitoring devices involve vital signs, continuous glucose, cardiac, and respiratory monitoring. Therapeutic devices include insulin delivery systems, nebulizers, dialysis machines, and infusion pumps. Data management systems cover point-of-care data integration, middleware solutions, and analytics platforms.

Emerging Industry Changes Shaping Point-of-Care Demand

Innovation within the point-of-care technology market is increasingly focused on developing AI-powered diagnostic tools to enhance accuracy, speed, and accessibility of disease detection. These advanced platforms utilize artificial intelligence to analyze medical data swiftly, allowing real-time, on-site testing for critical illnesses like cancer.

For instance, in February 2025, Avitia Inc., a Canadian diagnostics company, introduced an AI-based platform designed for rapid cancer testing at the point of care. This system combines machine learning algorithms with portable diagnostic devices, enabling healthcare professionals to conduct fast and precise cancer screenings outside traditional laboratory environments. Such technology reduces turnaround times, supports early diagnosis, and lowers the need for complex infrastructure, improving access to advanced diagnostics in underserved and remote regions.

Key Industry Players Leading the Point-of-Care Technology Market

The point-of-care technology market is highly competitive, with several major companies driving innovation and growth. Prominent players include F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Hologic Inc., bioMérieux SA, Quidel Corporation, Sysmex Corporation, Cepheid Inc., Radiometer Medical ApS, Nova Biomedical, Sekisui Diagnostics LLC, Abaxis Inc., BHR Biosynex, EKF Diagnostics Holdings plc, Acon Laboratories Inc., Trinity Biotech plc, Chembio Diagnostics Inc., Arkray Inc., Orchard Software Corporation, and Point of Care Biomedical Private Limited.

Regional Market Overview and Growth Opportunities

In 2025, North America maintained its position as the largest regional market for point-of-care technology. However, the Asia-Pacific region is expected to experience the fastest growth during the forecast period. The market analysis includes key regions such as Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, providing a comprehensive global perspective on market developments and opportunities.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model